Contributors |
|
xi | |
Foreword |
|
xv | |
|
|
SECTION-I Uses, Abuses, & Epidemiology |
|
|
|
|
3 | (2) |
|
|
Classification and Uses of Organophosphates and Carbamates |
|
|
5 | (20) |
|
|
Therapeutic Uses of Cholinesterase Inhibitors in Neurodegenerative Diseases |
|
|
25 | (10) |
|
|
|
Coadministration of Memantine with Acetylcholinesterase Inhibitors: Preclinical and Clinical Evidence |
|
|
35 | (12) |
|
|
Cholinesterase Inhibitors as Chemical Warfare Agents: Community Preparedness Guidelines |
|
|
47 | (22) |
|
|
|
|
|
|
|
Organophosphates and the Gulf War Syndrome |
|
|
69 | (10) |
|
|
The Bhopal Accident and Methyl Isocyanate Toxicity |
|
|
79 | (10) |
|
|
|
Global Epidemiology of Organophosphate and Carbamate Poisonings |
|
|
89 | (14) |
|
|
SECTION-II Pharmacokinetics & Metabolism |
|
|
|
Physiologically Based Pharmacokinetic Modeling of Organophosphorus and Carbamate Pesticides |
|
|
103 | (24) |
|
|
Metabolism of Organophosphorus and Carbamate Pesticides |
|
|
127 | (18) |
|
|
|
|
Interspecies Variation in Toxicity of Cholinesterase Inhibitors |
|
|
145 | (16) |
|
|
|
|
SECTION-III Esterases, Receptors, Mechanisms, & Tolerance Development |
|
|
|
Structure and Function of Cholinesterases |
|
|
161 | (26) |
|
|
|
Cholinesterase Pharmacogenetics |
|
|
187 | (12) |
|
|
Methods for Measuring Cholinesterase Activities in Human Blood |
|
|
199 | (10) |
|
|
|
Interactions of Organophosphorus and Carbamate Compounds with Cholinesterases |
|
|
209 | (10) |
|
|
Structure, Function, and Regulation of Carboxylesterases |
|
|
219 | (14) |
|
|
|
Noncholinesterase Mechanisms of Central and Peripheral Neurotoxicity: Muscarinic Receptors and Other Targets |
|
|
233 | (14) |
|
|
|
Paraoxonase Polymorphisms and Toxicity of Organophosphates |
|
|
247 | (10) |
|
|
|
|
|
Tolerance Development to Toxicity of Cholinesterase Inhibitors |
|
|
257 | (14) |
|
|
|
SECTION-IV Organ Toxicity |
|
|
|
Central Nervous System Effects and Neurotoxicity |
|
|
271 | (22) |
|
|
Developmental Neurotoxicity of Organophosphates: A Case Study of Chlorpyrifos |
|
|
293 | (22) |
|
|
In Vitro Models for Testing Organophosphate-Induced Neurotoxicity and Remediation |
|
|
315 | (24) |
|
Evelyn Tiffany-Castiglioni |
|
|
|
|
|
Electrophysiological Mechanisms in Neurotoxicity of Organophosphates and Carbamates |
|
|
339 | (8) |
|
|
Behavioral Toxicity of Cholinesterase Inhibitors |
|
|
347 | (14) |
|
|
|
Peripheral Nervous System Effects and Delayed Neuropathy |
|
|
361 | (10) |
|
|
|
Intermediate Syndrome in Organophosphate Poisoning |
|
|
371 | (10) |
|
|
Cardiovascular Toxicity of Cholinesterase Inhibitors |
|
|
381 | (8) |
|
|
|
|
Pulmonary Toxicity of Cholinesterase Inhibitors |
|
|
389 | (10) |
|
|
|
|
Approaches to Defining and Evaluating the Inhalation Pharmacology and Toxicology Hazards of Anticholinesterases |
|
|
399 | (12) |
|
|
|
Dermal Absorption/Toxicity of Organophosphates and Carbamates |
|
|
411 | (12) |
|
|
Local and Systemic Ophthalmic Pharmacology and Toxicology of Organophosphate and Carbamate Anticholinesterases |
|
|
423 | (24) |
|
|
Reproductive Toxicity of Organophosphate and Carbamate Pesticides |
|
|
447 | (16) |
|
|
|
Placental Toxicity of Organophosphate and Carbamate Pesticides |
|
|
463 | (18) |
|
|
|
|
Endocrine Disruption by Organophosphate and Carbamate Pesticides |
|
|
481 | (14) |
|
|
|
|
Organophosphates, Carbamates, and the Immune System |
|
|
495 | (16) |
|
|
SECTION-V Nonspecific Toxic Effects |
|
|
|
Oxidative Stress in Anticholinesterase-Induced Excitotoxicity |
|
|
511 | (22) |
|
|
|
|
DNA Damage, Gene Expression, and Carcinogenesis by Organophosphates and Carbamates |
|
|
533 | (16) |
|
|
|
|
Temperature Regulation in Experimental Mammals and Humans Exposed to Organophosphate and Carbamate Agents |
|
|
549 | (18) |
|
|
|
|
Occupational Toxicology and Occupational Hygiene Aspects of Organophosphate and Carbamate Anticholinesterases with Particular Reference to Pesticides |
|
|
567 | (32) |
|
|
|
SECTION-VI Risk Assessment & Regulations |
|
|
|
Public Health Impacts of Organophosphates and Carbamates |
|
|
599 | (8) |
|
|
Cumulative Effects of Organophosphorus or Carbamate Pesticides |
|
|
607 | (10) |
|
|
Federal Regulations and Risk Assessment of Organophosphate and Carbamate Pesticides |
|
|
617 | (16) |
|
|
Regulatory Considerations in Developmental Neurotoxicity of Organophosphorus and Carbamate Pesticides |
|
|
633 | (10) |
|
|
WHO/FAO Guidelines for Cholinesterase-Inhibiting Pesticide Residues in Food |
|
|
643 | (14) |
|
|
SECTION-VII Aquatic Life & Wildlife |
|
|
|
Aquatic Toxicity of Carbamates and Organophosphates |
|
|
657 | (16) |
|
|
|
Toxicity of Organophosphorus and Carbamate Insecticides Using Birds as Sentinels for Terrestrial Vertebrate Wildlife |
|
|
673 | (8) |
|
|
SECTION-VIII Analytical & Biomarkers |
|
|
|
Analysis of Organophosphate and Carbamate Pesticides and Anticholinesterase Therapeutic Agents |
|
|
681 | (22) |
|
|
Biomarkers of Organophosphate Exposure |
|
|
703 | (12) |
|
|
|
SECTION-IX Therapeutic Measures |
|
|
|
Management of Organophosphorus Pesticide Poisoning |
|
|
715 | (20) |
|
|
Index |
|
735 | |